>On the insurance front - expect your insurance to decline this forever unless you are at serious risk of diabetes.
I'm not understanding this part. If these drugs have solved obesity and the whole host of associated diseases, including the number one killer; heart disease, shouldn't the insurance companies be clambering over each other to cover these drugs and heavily encouraging their use considering the cost reduction on the overall health system.
And if the incentives are misaligned with insurance companies why are governments not handing out GLP-1s to anyone who asks?
This is something I've stuggled with for my site, I made https://aimodelreview.com/ to compare the outputs of LLMs over a variety of prompts and categories, allowing a side by side comparison between them. I ran each prompt 4 times for each model with different temperature values available as a toggles.
My thinking was to just make the responses available to users and let them see how models perform. But from some feedback, turns out users don't want to have to evaluate the answers and would rather see a leaderboard and rankings.
The scalable solution to that would be LLM as judge that some benchmarks already use, but that just feels wrong to me.
LM Arena tries to solve this with the crowd sourced solution, but I think the right method would have to be domain expert human reviewers, so like Wirecutter VS IMDb, but that is expensive to pull off.
I've suffered from dry eyes for many years and have tried all the over the counter options available in the US with no success, especially for overnight dryness. Could you please share a hint for the Irish pharmacy delivering to the US?